| Accession Number | 0001193125-26-382474 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 25,000 | $8.27 | $206,750.00 | 34,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Sep 1, 2026 | Sale | 11,730 | $113.94 | $1,336,458.72 | 23,025 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Sep 1, 2026 | Sale | 10,989 | $114.71 | $1,260,567.97 | 12,036 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Sep 1, 2026 | Sale | 2,281 | $115.61 | $263,710.52 | 9,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Sep 1, 2026 | Grant/Award | 150 | $113.38 | $17,007.00 | 9,905 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Sep 1, 2026 | Grant/Award | 150 | $0.00 | $0.00 | 10,055 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Sep 2, 2026 | Tax Withholding | 117 | $113.38 | $13,265.46 | 9,938 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Stock option (right to buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 66,986 | Direct | โ | View Details |